Overview
| Product name | Recombinant Human IL-17A&IL-17F Protein |
|---|
| Catalog No. | RP02414 |
|---|
| Description | Recombinant Human IL-17A&IL-17F heterodimer Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Gly24-Ala155(IL-17A)&Arg31-Gln163) of Human IL-17A&IL-17F heterodimer fused with His tag and Avi tag at the C-terminal. |
|---|
| Purity | > 95% by Tris-Bis PAGE;> 95% by SEC-HPLC |
|---|
| Endotoxin | < 1 EU/μg of the protein by LAL method. |
|---|
| Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. |
|---|
| Species | Human |
|---|
| Calculated MW | 15.1 kDa(IL-17A), 17.5 kDa(IL-17F) |
|---|
Product information
| Synonym | IL-17A; Interleukin-17A; CTLA-8; IL-17; IL-17F; IL24; ML-1; Interleukin-17F |
|---|
| Expression Host | HEK293 cells |
|---|
| Tag | C-His&Avi |
|---|
| Swiss-Prot | |
|---|
| Gene ID | |
|---|
Usage guide
| Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt.
After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
|---|
| Reconstitution | Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
|---|
* For research use only. Not for therapeutic or diagnostic purposes.
